Skip to main content
SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany flag Germany · Delayed Price · Currency is EUR
23.80
-0.22 (-0.92%)
At close: Mar 28, 2025, 5:30 PM CET

ETR:1SXP Revenue

SCHOTT Pharma AG & Co. KGaA had revenue of 229.84M EUR in the quarter ending December 31, 2024, a decrease of -1.04%. This brings the company's revenue in the last twelve months to 954.68M, up 5.42% year-over-year. In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M with 6.51% growth.

Revenue (ttm)
954.68M
Revenue Growth
+5.42%
P/S Ratio
3.75
Revenue / Employee
201.03K
Employees
4,690
Market Cap
3.58B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024957.09M58.49M6.51%
Sep 30, 2023898.60M77.46M9.43%
Sep 30, 2022821.14M172.48M26.59%
Sep 30, 2021648.67M64.44M11.03%
Sep 30, 2020584.23M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.16B
Siemens Healthineers AG 22.67B
Fresenius SE & Co. KGaA 21.83B
Bayer Aktiengesellschaft 46.61B
Sartorius Aktiengesellschaft 3.38B
Fresenius Medical Care AG 19.34B
Carl Zeiss Meditec AG 2.08B
Fielmann Group AG 2.16B
Revenue Rankings

SCHOTT Pharma AG & Co. KGaA News

More News